HIDRADENITIS SUPPURATIVA
Clinical trials for HIDRADENITIS SUPPURATIVA explained in plain language.
Never miss a new study
Get alerted when new HIDRADENITIS SUPPURATIVA trials appear
Sign up with your email to follow new studies for HIDRADENITIS SUPPURATIVA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for painful skin condition: experimental drug enters phase 2 trial
Symptom relief Not yet recruitingThis study tests whether the experimental drug LAD328 can reduce symptoms of moderate-to-severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. About 50 adults will receive either LAD328 or a placebo to compare effectiveness and safety. The main goal is …
Matched conditions: HIDRADENITIS SUPPURATIVA
Phase: PHASE2 • Sponsor: Almirall, S.A. • Aim: Symptom relief
Last updated May 17, 2026 06:47 UTC
-
Italian skin disease registry aims to map Real-World treatment patterns
Knowledge-focused Not yet recruitingThis study will look at existing medical records from 20,000 people aged 12 and older in Italy who have psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to learn about the types of treatments patients receive, how their diseas…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated May 17, 2026 07:05 UTC
-
Can an HS drug keep your heart arteries clear? new study investigates
Knowledge-focused Not yet recruitingThis study will follow 34 adults with moderate-to-severe hidradenitis suppurativa (HS) who are taking the drug secukinumab as part of their regular care. Researchers want to see if the drug can slow or prevent the buildup of plaque in the heart arteries over 12 months. Participan…
Matched conditions: HIDRADENITIS SUPPURATIVA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 06:49 UTC